Recombinant multi-species Keratin 81/KRT81 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Keratin 81/KRT81 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the keratin gene family. As a type II hair keratin, it is a basic protein which heterodimerizes with type I keratins to form hair and nails. The type II hair keratins are clustered in a region of chromosome 12q13 and are grouped into two distinct subfamilies based on structure similarity. One subfamily, consisting of KRTHB1, KRTHB3, and KRTHB6, is highly related. The other less-related subfamily includes KRTHB2, KRTHB4, and KRTHB5. All hair keratins are expressed in the hair follicle; this hair keratin, as well as KRTHB3 and KRTHB6, is found primarily in the hair cortex. Mutations in this gene and KRTHB6 have been observed in patients with a rare dominant hair disease, monilethrix. Some human genome assemblies (example T2T-CHM13) have a non-coding version of the gene due to the presence of a SNP that introduces a premature stop codon after codon 281. [provided by RefSeq, Jan 2024]
The Alternative Names of target: 1,HB1,Hair keratin K2.9,Hb-1,K81,KRT81,KRTHB1,Keratin,Keratin 81,Keratin-81 (K81),MLN137,Metastatic lymph node 137 gene protein (MLN 137),Type II hair keratin Hb1,Type-II keratin Kb21,basic,ghHKb1 (ghHb1),ghHkb1,hHAKB2-1,hair,type II cuticular Hb1
Go
to Keratin 81/KRT81 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8522-Ag-1/ GM-Tg-hg-IP8522-Ag-2 | Human Keratin 81/KRT81 protein | Human |
| GM-Tg-rg-IP8522-Ag-1/ GM-Tg-rg-IP8522-Ag-2 | Rat Keratin 81/KRT81 protein | Rat |
| GM-Tg-mg-IP8522-Ag-1/ GM-Tg-mg-IP8522-Ag-2 | Mouse Keratin 81/KRT81 protein | Mouse |
| GM-Tg-cynog-IP8522-Ag-1/ GM-Tg-cynog-IP8522-Ag-2 | Cynomolgus/Rhesus macaque Keratin 81/KRT81 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8522-Ag-1/ GM-Tg-felg-IP8522-Ag-2 | Feline Keratin 81/KRT81 protein | Feline |
| GM-Tg-cang-IP8522-Ag-1/ GM-Tg-cang-IP8522-Ag-2 | Canine Keratin 81/KRT81 protein | Canine |
| GM-Tg-bovg-IP8522-Ag-1/ GM-Tg-bovg-IP8522-Ag-2 | Bovine Keratin 81/KRT81 protein | Bovine |
| GM-Tg-equg-IP8522-Ag-1/ GM-Tg-equg-IP8522-Ag-2 | Equine Keratin 81/KRT81 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8522-Ag-1/ GM-Tg-hg-IP8522-Ag-2;
GM-Tg-rg-IP8522-Ag-1/ GM-Tg-rg-IP8522-Ag-2;
GM-Tg-mg-IP8522-Ag-1/ GM-Tg-mg-IP8522-Ag-2; GM-Tg-cynog-IP8522-Ag-1/ GM-Tg-cynog-IP8522-Ag-2; GM-Tg-felg-IP8522-Ag-1/ GM-Tg-felg-IP8522-Ag-2; GM-Tg-cang-IP8522-Ag-1/ GM-Tg-cang-IP8522-Ag-2; GM-Tg-bovg-IP8522-Ag-1/ GM-Tg-bovg-IP8522-Ag-2; GM-Tg-equg-IP8522-Ag-1/ GM-Tg-equg-IP8522-Ag-2 |
| Products Name | Keratin 81/KRT81 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Keratin 81/KRT81 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Keratin 81/KRT81 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.